Table 2. Comparing the ADL and IADL scores at baseline and 1, 3, 6, and 12 months of follow-up in groups with delirium.
Time of follow-up (months) | |||||||||
Non-adjusted functional status (mean ± SE) | Adjusted baseline functional status by ANCOVA (mean ± SE) | ||||||||
Outcomes variables | Baseline | 1 | 3 | 6 | 12 | 1 | 3 | 6 | 12 |
ADL (BI) scores (mean ± SE) | |||||||||
Delirium (N = 17) | 85.9±4.81# | 77.9±5.25# | 79.4±5.62# | 81.8±5.44# | 81.8±5.86# | 83.0±2.82# | 84.5±2.77# | 86.9±3.06# | 86.4±3.18# |
No delirium (N = 165) | 95.6±0.80 | 93.2±0.93 | 94.9±0.89 | 95.2±1.00 | 95.6±0.99 | 92.7±0.88 | 94.4±0.87 | 94.6±0.96 | 95.2±1.00 |
IADL scores (mean ± SE) | |||||||||
Delirium (N = 17) | 4.4±0.40# | 3.4±0.45# | 3.4±0.47# | 3.2±0.53# | 2.9±0.53# | 4.4±0.28# | 4.4±0.28# | 4.3±0.33# | 4.0±0.33# |
No delirium (N = 165) | 5.8±0.09 | 5.3±0.11 | 5.6±0.11 | 5.6±0.12 | 5.7±0.12 | 5.2±0.09 | 5.5±0.09 | 5.5±0.10 | 5.6±0.10 |
p<0.05 for comparing groups by delirium status. ANCOVA: Analysis of Covariance.